NCT04597671
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04597671
Title Durvalumab and Low-dose PCI vs Durvalumab and Observation in Radically Treated Patients With Stage III NSCLC (NVALT28) (NVALT28)
Acronym NVALT28
Recruitment Active, not recruiting
Gender both
Phase Phase III
Variant Requirements No
Sponsors Association NVALT Studies
Indications
Therapies
Age Groups: senior | adult
Covered Countries NLD

Facility Status City State Zip Country Details
ZGT Almelo Netherlands Details
AmsterdamUMC - location VUmc Amsterdam Netherlands Details
Radiotherapie Groep Arnhem Netherlands Details
Rijnstate Arnhem Netherlands Details
Gelderse Vallei Ede Netherlands Details
Catharina Ziekenhuis Eindhoven Netherlands Details
ZRTI Flushing Netherlands Details
UMCG Groningen Netherlands Details
Maastro Maastricht 5912 BL Netherlands Details
Canisius Wilhemina Ziekenhuis Nijmegen Netherlands Details
Radboud UMC Nijmegen Netherlands Details
ZorgSaam Ziekenhuis Terneuzen Netherlands Details
Maxima Medisch Centrum Veldhoven Netherlands Details
Zaans Medisch Centrum Zaandam Netherlands Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field